How much does coffee lower your risk of cirrhosis?
The protection is substantial and dose-dependent—meaning the more coffee you drink, the lower your risk tends to be. A 2016 meta-analysis that combined nine studies (including over 430,000 participants) found that each additional two cups of coffee per day was associated with a 44% lower risk of cirrhosis (relative risk 0.56) [3]. Another meta-analysis from the same year, covering 16 studies, found that any coffee consumption reduced the odds of cirrhosis by 39% (odds ratio 0.61), and high consumption (more than 2 cups/day) cut the risk by nearly half (odds ratio 0.53) [4].
The largest single study to date, the UK Biobank analysis of nearly 500,000 people, tracked participants for over a decade and found that coffee drinkers had a 21% lower risk of developing chronic liver disease and a 49% lower risk of dying from it compared to non-drinkers [1]. This protection was seen for all types of coffee—decaf, instant, and ground—suggesting the benefit isn't just from caffeine [1].
Does it work for all types of cirrhosis?
The evidence is strongest for alcohol-related cirrhosis, but protection also extends to other causes. A landmark 2006 study of over 125,000 people found that drinking 4 or more cups of coffee per day reduced the risk of alcoholic cirrhosis by 80% (relative risk 0.2) [5]. For non-alcoholic cirrhosis, the same study found a smaller, non-significant trend toward protection [5]. A 2021 study of heavy drinkers confirmed that coffee drinkers had a significantly lower risk of alcohol-related cirrhosis than non-drinkers, even after accounting for the amount of alcohol consumed [6].
The protection also applies to people with existing liver damage. A randomized controlled trial in 2024 gave 400 mg of caffeine daily (equivalent to about 4 cups of coffee) to patients with cirrhosis and found significant improvements in liver fibrosis scores and reductions in inflammatory markers after just 8 weeks [2]. Another study of patients with end-stage liver disease awaiting transplant found that coffee drinkers survived an average of 14.5 months longer than non-drinkers [7].
How might coffee protect the liver?
The exact mechanism isn't fully understood, but several pathways are likely involved. Coffee contains hundreds of bioactive compounds, including antioxidants and anti-inflammatory agents. The 2024 clinical trial showed that caffeine supplementation reduced inflammatory biomarkers and improved liver function tests in cirrhotic patients, suggesting a direct anti-inflammatory effect [2]. Coffee also appears to lower liver enzyme levels—the 2006 study found that people who drank 4 or more cups per day had 50% lower odds of having elevated AST (a marker of liver damage) [5].
Importantly, the benefit is not solely due to caffeine, since decaf coffee also shows protective effects [1]. This points to other compounds in coffee, such as chlorogenic acids and diterpenes, which have antioxidant properties. One study even suggested that coffee's antagonism of adenosine receptors might help suppress cancer cell growth, which could explain why coffee drinkers also have lower rates of liver cancer [8].
About These Sources
This answer is built on 8 peer-reviewed studies — published from 2006 to 2024, 1 from 2024 or later, 1 in Q1 journals, collectively cited 55 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 61 papers retrieved from a database of over 500 million.
Sources used in this answer
All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study
In a UK Biobank cohort of 494,585 participants followed for a median of 10.7 years, coffee drinkers had a 21% lower risk of chronic liver disease and a 49% lower risk of death from liver disease compared to non-drinkers, with similar protection from decaf, instant, and ground coffee.
Caffeine supplement, inflammation, and hepatic function in cirrhotic patients: A randomized, placebo- controlled, clinical trial
In a randomized, double-blind, placebo-controlled trial of 50 cirrhotic patients, 400 mg/day of caffeine for 8 weeks significantly reduced inflammatory biomarkers and improved liver fibrosis scores (APRI, FIB-4, MELD) compared to placebo.
Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis.
A meta-analysis of 5 cohort and 4 case-control studies (1,990 cirrhosis cases, 432,133 participants) found that each additional 2 cups of coffee per day reduced the risk of cirrhosis by 44% (RR 0.56), with similar effects for alcoholic cirrhosis and cirrhosis death.
Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis.
A meta-analysis of 16 studies (3,034 coffee consumers, 132,076 non-consumers) found that any coffee consumption reduced the odds of cirrhosis by 39% (OR 0.61) and high consumption (>2 cups/day) reduced it by 47% (OR 0.53); coffee also reduced the risk of advanced hepatic fibrosis by 27% (OR 0.73).
Coffee, cirrhosis, and transaminase enzymes.
In a cohort of 125,580 health plan members followed for up to 23 years, drinking 4+ cups of coffee per day was associated with an 80% lower risk of alcoholic cirrhosis (RR 0.2) and with 50% lower odds of elevated liver enzymes (AST, ALT).
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers.
In a case-control study of 1,293 alcohol-related cirrhosis cases and 754 heavy-drinking controls, coffee consumption was significantly more common among controls (no liver disease), suggesting a protective effect; findings were replicated in UK Biobank.
Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation.
In a study of 379 patients with end-stage liver disease awaiting transplant, coffee drinkers survived an average of 14.5 months longer than non-drinkers; among 260 post-transplant patients, coffee drinkers also had longer survival (61.8 vs 52.3 months).
Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis.
In a study of 90 patients who received liver transplants for hepatocellular carcinoma, postoperative coffee consumption of ≥3 cups/day was associated with a 70% lower risk of HCC recurrence and significantly longer overall survival (11.0 vs 7.5 years).